[Federal Register Volume 75, Number 171 (Friday, September 3, 2010)]
[Notices]
[Page 54232]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-22017]


-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Internal Revenue Service


Proposed Collection; Comment Request for Report of Covered 
Pharmaceutical Manufacturers and Importers (Form-8947)

AGENCY: Internal Revenue Service (IRS), Treasury.

ACTION: Notice and request for comments.

-----------------------------------------------------------------------

SUMMARY: The Department of the Treasury, as part of its continuing 
effort to reduce paperwork and respondent burden, invites the general 
public and other Federal agencies to take this opportunity to comment 
on proposed and/or continuing information collections, as required by 
the Paperwork Reduction Act of 1995, Public Law 104-13 (44 U.S.C. 
3506(c)(2)(A)). Currently, the IRS is soliciting comments concerning 
Form-8947, Report of Covered Pharmaceutical Manufacturers and 
Importers.

DATES: Written comments should be received on or before November 2, 
2010 to be assured of consideration.

ADDRESSES: Direct all written comments to Gerald Shields, Internal 
Revenue Service, room 6129, 1111 Constitution Avenue, NW., Washington, 
DC 20224.

FOR FURTHER INFORMATION CONTACT: Requests for additional information or 
copies of the form and instructions should be directed to Elaine 
Christophe, (202) 622-3179, or at Internal Revenue Service, Room 6129, 
1111 Constitution Avenue, NW., Washington, DC 20224, or through the 
internet, at <a href="/cdn-cgi/l/email-protection#43062f222a2d266d0b6d002b312a30372c332b26032a31306d242c35"><span class="__cf_email__" data-cfemail="84c1e8e5edeae1aaccaac7ecf6edf7f0ebf4ece1c4edf6f7aae3ebf2">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION:
    Title: Report of Covered Pharmaceutical Manufacturers and 
Importers.
    OMB Number: 1545-XXXX.
    Form Number: Report of Covered Pharmaceutical Manufacturers and 
Importers Form-8947).
    Abstract: Report of Covered Pharmaceutical Manufacturers and 
Importers allows for fee to be assessed against entities selling 
branded prescription drugs to specified government agencies, based in 
part on controlled group status and credits allowed for qualified 
``orphan drugs.''
    Current Actions: This new form is being submitted to OMB for 
approval and a new OMB control number.
    Type of Review: New Collection.
    Affected Public: Businesses and other for-profit organizations.
    Estimated Number of Respondents: 400.
    Estimated Time per Respondent Recordkeeping: 6 Hours, 28 minutes.
    Estimated Time per Respondent Learning: 1 Hour, 17 minutes.
    Estimated Time per Respondent Preparing: 1 Hour, 27 minutes.
    Estimated Total Annual Burden Hours: 3,680 Hours.
    The following paragraph applies to all of the collections of 
information covered by this notice:
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless the collection of 
information displays a valid OMB control number.
    Books or records relating to a collection of information must be 
retained as long as their contents may become material in the 
administration of any internal revenue law. Generally, tax returns and 
tax return information are confidential, as required by 26 U.S.C. 6103.
    Request for Comments: Comments submitted in response to this notice 
will be summarized and/or included in the request for OMB approval. All 
comments will become a matter of public record.
    Comments are invited on: (a) Whether the collection of information 
is necessary for the proper performance of the functions of the agency, 
including whether the information shall have practical utility; (b) the 
accuracy of the agency's estimate of the burden of the collection of 
information; (c) ways to enhance the quality, utility, and clarity of 
the information to be collected; (d) ways to minimize the burden of the 
collection of information on respondents, including through the use of 
automated collection techniques or other forms of information 
technology; and (e) estimates of capital or start-up costs and costs of 
operation, maintenance, and purchase of services to provide 
information.

    Approved: August 26, 2010.
Gerald Shields,
IRS Supervisory Tax Analyst.
[FR Doc. 2010-22017 Filed 9-2-10; 8:45 am]
BILLING CODE 4830-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>